Who has been buying Apureus stock?

3 distinct insiders have filed 0 disclosed insider purchases in Apureus (149300), most recently on 2025-12-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Apureus have?

Apureus has 0 buy-side and 135 sell-side disclosures on record, covering ₩275M ($191K) in total reported value, spanning 2019-09-03 to 2025-12-26.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Apureus 149300

Company

아퓨어스Apureus

Insiders

Buys

Total Value

₩275M ($191K)

Avg Return

+35.84%

Last Filing

2025-12-26

Apureus (149300) has 0 disclosed insider purchases and 135 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩275M ($191K) in reported transaction value. The earliest filing StockDrifts holds for Apureus is dated 2019-09-03; the most recent is 2025-12-26. Across these filings the average return since disclosure is +35.84%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2025-12-26	SELL	Market Sell	KB솔리더스글로벌헬스케어펀드 KB Solidus Global Healthcare Fund	-	-339.2K	₩23	-65.2%	₩8M ($5K)
2025-12-26	SELL	Market Sell	메디제네틱스 Medigenetics	-	-437.6K	₩23	-65.2%	₩10M ($7K)
2025-12-24	SELL	Market Sell	메디제네틱스 Medigenetics	-	-52.7K	₩26	-46.1%	₩1M ($951)
2025-12-24	SELL	Market Sell	KB솔리더스글로벌헬스케어펀드 KB Solidus Global Healthcare Fund	-	-196.0K	₩26	-46.1%	₩5M ($4K)
2025-12-23	SELL	Market Sell	KB솔리더스글로벌헬스케어펀드 KB Solidus Global Healthcare Fund	-	-427.0K	₩28	-35.7%	₩12M ($8K)
2025-12-23	SELL	Market Sell	메디제네틱스 Medigenetics	-	-191.2K	₩28	-35.7%	₩5M ($4K)
2025-12-22	SELL	Market Sell	메디제네틱스 Medigenetics	-	-150.0K	₩32	-18.8%	₩5M ($3K)
2025-12-19	SELL	Market Sell	메디제네틱스 Medigenetics	-	-12.2K	₩37	-2.7%	₩450K ($313)
2025-12-18	SELL	Market Sell	메디제네틱스 Medigenetics	-	-200.0K	₩43	+11.6%	₩9M ($6K)
2025-12-17	SELL	Market Sell	메디제네틱스 Medigenetics	-	-5.0K	₩43	+11.6%	₩215K ($149)
2025-12-16	SELL	Market Sell	메디제네틱스 Medigenetics	-	-310.0K	₩44	+13.6%	₩14M ($9K)
2025-12-15	SELL	Market Sell	메디제네틱스 Medigenetics	-	-8.2K	₩49	+22.4%	₩402K ($279)
2025-12-12	SELL	Market Sell	메디제네틱스 Medigenetics	-	-257.6K	₩44	+13.6%	₩11M ($8K)
2025-12-11	SELL	Market Sell	메디제네틱스 Medigenetics	-	-115.2K	₩50	+24.0%	₩6M ($4K)
2025-12-10	SELL	Market Sell	메디제네틱스 Medigenetics	-	-30.3K	₩50	+24.0%	₩2M ($1K)
2025-12-09	SELL	Market Sell	메디제네틱스 Medigenetics	-	-20.0K	₩53	+28.3%	₩1M ($736)
2025-12-08	SELL	Market Sell	메디제네틱스 Medigenetics	-	-170.2K	₩55	+30.9%	₩9M ($6K)
2025-12-05	SELL	Market Sell	메디제네틱스 Medigenetics	-	-21.8K	₩56	+32.1%	₩1M ($849)
2025-12-04	SELL	Market Sell	메디제네틱스 Medigenetics	-	-26.2K	₩54	+29.6%	₩1M ($984)
2025-12-03	SELL	Market Sell	메디제네틱스 Medigenetics	-	-21.5K	₩60	+36.7%	₩1M ($896)
2025-12-02	SELL	Market Sell	메디제네틱스 Medigenetics	-	-13.4K	₩65	+41.5%	₩874K ($607)
2025-12-01	SELL	Market Sell	메디제네틱스 Medigenetics	-	-22.6K	₩70	+45.7%	₩2M ($1K)
2025-11-28	SELL	Market Sell	메디제네틱스 Medigenetics	-	-13.0K	₩67	+43.3%	₩870K ($604)
2025-11-27	SELL	Market Sell	메디제네틱스 Medigenetics	-	-6	₩67	+43.3%	₩402 ($0)
2025-11-26	SELL	Market Sell	메디제네틱스 Medigenetics	-	-3	₩65	+41.5%	₩195 ($0)
2025-11-25	SELL	Market Sell	메디제네틱스 Medigenetics	-	-1	₩66	+42.4%	₩66 ($0)
2025-11-24	SELL	Market Sell	메디제네틱스 Medigenetics	-	-204	₩65	+41.5%	₩13K ($9)
2025-11-19	SELL	Market Sell	메디제네틱스 Medigenetics	-	-1.4K	₩65	+41.5%	₩91K ($63)
2025-11-18	SELL	Market Sell	메디제네틱스 Medigenetics	-	-23.0K	₩65	+41.5%	₩1M ($1K)
2025-11-17	SELL	Market Sell	메디제네틱스 Medigenetics	-	-7.1K	₩64	+40.6%	₩457K ($317)
2025-11-14	SELL	Market Sell	메디제네틱스 Medigenetics	-	-3.1K	₩64	+40.6%	₩196K ($136)
2025-11-13	SELL	Market Sell	메디제네틱스 Medigenetics	-	-6.7K	₩69	+44.9%	₩459K ($319)
2025-11-12	SELL	Market Sell	메디제네틱스 Medigenetics	-	-166.3K	₩70	+45.7%	₩12M ($8K)
2025-11-11	SELL	Market Sell	메디제네틱스 Medigenetics	-	-5.1K	₩69	+44.9%	₩350K ($243)
2025-11-10	SELL	Market Sell	메디제네틱스 Medigenetics	-	-617	₩68	+44.1%	₩42K ($29)
2025-11-07	SELL	Market Sell	메디제네틱스 Medigenetics	-	-3.5K	₩63	+39.7%	₩220K ($153)
2025-11-06	SELL	Market Sell	메디제네틱스 Medigenetics	-	-62.9K	₩62	+38.7%	₩4M ($3K)
2025-11-05	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-25.9K	₩64	+40.6%	₩2M ($1K)
2025-08-05	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-10	₩63	+39.7%	₩630 ($0)
2025-08-04	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-2.2K	₩57	+33.3%	₩124K ($86)
2025-08-01	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-35.9K	₩52	+26.9%	₩2M ($1K)
2025-07-31	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-50.1K	₩50	+24.0%	₩3M ($2K)
2025-07-30	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-5.2K	₩50	+24.0%	₩260K ($181)
2025-07-28	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-48.0K	₩51	+25.5%	₩2M ($2K)
2025-07-25	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-116.6K	₩50	+24.0%	₩6M ($4K)
2025-07-24	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-4.2K	₩51	+25.5%	₩212K ($147)
2025-07-23	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-14.6K	₩51	+25.5%	₩742K ($515)
2025-07-22	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-22.1K	₩50	+24.0%	₩1M ($767)
2025-07-21	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-302.0K	₩51	+25.5%	₩15M ($11K)
2025-07-18	SELL	Market Sell	최선덕 Choi Seon-deok	CEO	-10.9K	₩51	+25.5%	₩554K ($385)

Showing the 50 most recent of 136 filings.

Frequently asked questions

Who has been buying Apureus stock?: 3 distinct insiders have filed 0 disclosed insider purchases in Apureus (149300), most recently on 2025-12-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Apureus have?: Apureus has 0 buy-side and 135 sell-side disclosures on record, covering ₩275M ($191K) in total reported value, spanning 2019-09-03 to 2025-12-26.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.